Announced Sat, 4 Jul · 17:47 IST
Sarda Proteins board approves capital hike and leadership change
Corporate Actions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Board approved raising authorized share capital from Rs 13 crore to Rs 100 crore and altering the MOA, subject to shareholder approval at an upcoming EGM. Chirag Thumar resigned as Managing Director; Shirish Savaliya appointed as new MD for 5 years. CFO Yagnik Satasiya moved to Chairperson role; Drashti Delvadiya appointed as new CFO. Three other directors also resigned. Committees were reconstituted.
Likely market impact
Major leadership overhaul and big jump in authorized capital. Shareholders to vote on changes at upcoming EGM. Watch for any fund-raising plans.